Comments
Loading...
Redhill Biopharma (RDHL) Forecast
NewsEarningsRedhill Biopharma (RDHL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRedhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary
Redhill Biopharma Stock (NASDAQ: RDHL) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Redhill Biopharma (RDHL) stock?
You can purchase shares of Redhill Biopharma (NASDAQ:RDHL) through any online brokerage.
Who are Redhill Biopharma (RDHL) competitors?
Other companies in Redhill Biopharma’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
What is the forecast, or price target, for Redhill Biopharma (RDHL) stock?
There is no analysis for Redhill Biopharma to provide a consensus price target.
What is the current price for Redhill Biopharma (RDHL)?
The stock price for Redhill Biopharma (NASDAQ: RDHL) is $6.66 last updated November 20, 2024 at 10:47 AM EST.
Does Redhill Biopharma (RDHL) pay a dividend?
There are no upcoming dividends for Redhill Biopharma.
When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?
Redhill Biopharma’s Q2 earnings are confirmed for Tuesday, December 3, 2024.
Is Redhill Biopharma (RDHL) going to split?
There is no upcoming split for Redhill Biopharma.
What sector and industry does Redhill Biopharma (RDHL) operate in?
Redhill Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.